Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A3DHEU / Symbol: NVIV / Name: InVivo Therapeutics Holdings / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

InVivo Therapeutics Holdings Stock

So far the community has only identified positive things for InVivo Therapeutics Holdings stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of InVivo Therapeutics Holdings in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of InVivo Therapeutics Holdings vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
InVivo Therapeutics Holdings - - - - - - -
Atossa Genetics Inc -0.320% -3.115% -1.582% 69.598% 32.200% -56.955% -32.720%
Medmira Inc. -4.000% -3.030% -5.882% -20.000% -26.154% - -
Theralase Technologies Inc 6.190% 0.503% -8.257% -30.556% -3.846% -22.481% -33.906%

Comments

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NVIV provided by MarketBeat
Show more

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NVIV provided by MarketBeat
Show more

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NVIV provided by MarketBeat
Show more